Sun.Sep 13, 2020

article thumbnail

Gilead to buy cancer drugmaker Immunomedics for $21B

Bio Pharma Dive

The acquisition caps an active year of dealmaking for Gilead, which under CEO Daniel O'Day aims to become as well known for its cancer drugs as its HIV and hepatitis C medicines.

Medicine 264
article thumbnail

Vaccine Makers Keep Safety Details Quiet, Alarming Scientists

NY Times

Researchers say drug companies need to be more open about how vaccine trials are run to reassure Americans who are skittish about getting a coronavirus vaccine.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Depression risk detected by measuring heart rate changes

Scienmag

Credit: IMEC For the first time doctors have shown that measuring changes in 24-hour heart rate can reliably indicate whether or not someone is depressed. In practical terms, this may give clinicians an objective “early warning” of potential depression, as well as a rapid indication whether or not treatment is working, so opening the way […].

Doctors 71
article thumbnail

Association of Sleep Duration and Variability With Body Mass Index

JAMA Internal Medicine

This cohort study examines sleep and demographic data from wearable activity tracking devices to assess for an association of sleep duration and variability with body mass index.

75
article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Gun laws in neighboring states affect state gun deaths, new evidence

Scienmag

Weaker gun laws in neighboring states appear to increase gun deaths in adjoining states, and strong gun laws may be negated by more permissive laws among neighboring states, according to the American Journal of Preventive Medicine Credit: “Neighbors Do Matter: Between-State Firearm Laws and State Firearm-Related Deaths in the US, 2000-2017, ” by Ye Liu, […].

article thumbnail

Identifying Recommendations for Stopping or Scaling Back Unnecessary Services in Primary Care

JAMA Internal Medicine

This systematic review describes recommendations made by an expert panel across internal medicine disciplines on decreasing the frequency of or discontinuing testing and therapy not deemed to be necessary.

More Trending

article thumbnail

Coronavirus: 'Rule of six' comes into effect in England

The Pharma Data

Image copyright. Reuters. Restrictions banning social gatherings of more than six people have come into effect in England, following a rise in coronavirus cases. The “rule of six”, which applies both indoors and outdoors, does not exempt children under 12 in England. Similar restrictions in Wales and Scotland do not include children under 11 and 12 respectively.

52
article thumbnail

For diverse corporate board members, upward mobility stops with a seat at the table

Scienmag

Leadership positions continue to elude qualified directors who are female and/or racial minorities Credit: University of Delaware/ Julie Morin Recent protests across the United States and the world have put a magnifying glass on issues of diversity and equity. A new study explores the ways in which these issues go all the way to the […].

52
article thumbnail

Patent delisted for Astrazeneca Ab drug BYDUREON PEN

Drug Patent Watch

Annual Drug Patent Expirations for BYDUREON+PEN Bydureon Pen is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-nine…. The post Patent delisted for Astrazeneca Ab drug BYDUREON PEN appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Coronavirus: Care homes in England warned of rise in infections

The Pharma Data

Image copyright. Getty Images. The government has written to care home providers in England to warn them of a rise in new coronavirus infections within the sector. A letter from the Department of Health urged care bosses to take “necessary action to prevent and limit outbreaks” Cases were mainly among staff but risked spreading to residents, it said.

article thumbnail

Roles and Responsibilities of Specialized Clinical Supply Experts

When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.

article thumbnail

Patent delisted for Acorda drug AMPYRA

Drug Patent Watch

Annual Drug Patent Expirations for AMPYRA Ampyra is a drug marketed by Acorda and is included in one NDA. It is available from two suppliers. Drug patent litigation for AMPYRA.…. The post Patent delisted for Acorda drug AMPYRA appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

When methane-eating microbes eat ammonia instead

Scienmag

Some microorganisms, the so-called methanotrophs, make a living by oxidizing methane (CH4) to carbon dioxide (CO2). Ammonia (NH3) is structurally very similar to methane, thus methanotrophs also co-metabolize ammonia and produce nitrite. While this process was observed in cell cultures, the underlying biochemical mechanism was not understood. Boran Kartal, head of the Microbial Physiology Group […].

45
article thumbnail

Patent delisted for Purdue Pharma drug OXYCONTIN

Drug Patent Watch

Annual Drug Patent Expirations for OXYCONTIN Oxycontin is a drug marketed by Purdue Pharma Lp and is included in one NDA. It is available from eight suppliers. There are twenty-three…. The post Patent delisted for Purdue Pharma drug OXYCONTIN appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Asthma patients given risky levels of steroid tablets

Scienmag

More than one quarter of asthma patients have been prescribed potentially dangerous amounts of steroid tablets, with researchers warning this puts them at greater risk of serious side-effects. Researchers, led by University of Queensland Professor John Upham, analysed data from the Pharmaceutical Benefits Scheme (PBS) to find out how often Australians with asthma were taking […].

article thumbnail

The New Age of Decentralized Clinical Trials

This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.

article thumbnail

Patent delisted for Boehringer Ingelheim drug TRADJENTA

Drug Patent Watch

Annual Drug Patent Expirations for TRADJENTA Tradjenta is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from three suppliers. There are nine patents…. The post Patent delisted for Boehringer Ingelheim drug TRADJENTA appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Baby heartbeat reveals the stress of having a depressed or anxious mother

Scienmag

Scientists have shown that the babies of mothers dealing with anxiety or depression exhibit physiologically stronger signs of stress than babies of healthy mothers, when given a standard stress test. These babies show a significantly increased heart rate, which researchers fear may lead to imprinted emotional stresses as the child grows up. The interaction of […].

article thumbnail

Patent delisted for Boehringer Ingelheim drug JENTADUETO

Drug Patent Watch

Annual Drug Patent Expirations for JENTADUETO Jentadueto is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from one supplier. There are twelve patents…. The post Patent delisted for Boehringer Ingelheim drug JENTADUETO appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

As domestic violence spikes, many victims and their children have nowhere to live

Scienmag

Providing safe housing and community resources are critical to enhancing the safety of domestic violence victims and their children, says a Rutgers expert COVID-19 has left many victims of domestic violence facing difficulties feeding their children and accessing services for safe housing, transportation and childcare once they leave shelters, according to a Rutgers study published […].

article thumbnail

Accelerating Clinical Supply Through Integrated Drug Development

As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.

article thumbnail

Patent delisted for Circassia drug TUDORZA PRESSAIR

Drug Patent Watch

Annual Drug Patent Expirations for TUDORZA+PRESSAIR Tudorza Pressair is a drug marketed by Circassia and is included in one NDA. It is available from one supplier. There are nine patents…. The post Patent delisted for Circassia drug TUDORZA PRESSAIR appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Improved early psychosis detection system may halve risk in young people

Scienmag

Doctors have developed a new data mining method to detect many young people with emerging psychosis. The new methods, based on advanced data mining to pick up early risk sign from schools, hospitals, and general doctors, will be presented at the ECNP virtual congress, and is in press with a peer-reviewed journal (* see notes, […].

Doctors 40
article thumbnail

Patent delisted for Boehringer Ingelheim drug JARDIANCE

Drug Patent Watch

Annual Drug Patent Expirations for JARDIANCE Jardiance is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from four suppliers. There are six patents…. The post Patent delisted for Boehringer Ingelheim drug JARDIANCE appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Microscopio Portatile Digitale 1000X Endoscopio Con Cavo Usb Camera 8 Led Pc

BioTech 365

EUR 15,90Scadenza: sabato set-19-2020 18:05:01 CESTCompralo Subito per soli: EUR 15,90Compralo Subito | Aggiungi all’elenco degli oggetti che osservi Biotech365 : Microscopio Portatile Digitale 1000X Endoscopio Con Cavo Usb Camera 8 Led Pc BioMarketplace You want to propose your products … Continue reading →

article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Patent delisted for Purdue Pharma drug TARGINIQ

Drug Patent Watch

Annual Drug Patent Expirations for TARGINIQ Targiniq is a drug marketed by Purdue Pharma Lp and is included in one NDA. There are fifteen patents protecting this drug. Drug patent…. The post Patent delisted for Purdue Pharma drug TARGINIQ appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

LEITZ POLARISATION MIKROSKOP POL – MICROSCOPE ERNST LEITZ

BioTech 365

EUR 1,00 (0 Gebote)Angebotsende: Sonntag Sep-20-2020 19:10:52 CESTJetzt bieten | Zur Liste der beobachteten Artikel hinzufügen Biotech365 : LEITZ POLARISATION MIKROSKOP POL – MICROSCOPE ERNST LEITZ BioMarketplace You want to propose your products or a Biotech Company, a Biotech Tool … Continue reading →

article thumbnail

Patent delisted for Boehringer Ingelheim drug OFEV

Drug Patent Watch

Annual Drug Patent Expirations for OFEV Ofev is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from one supplier. There are five patents…. The post Patent delisted for Boehringer Ingelheim drug OFEV appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Simul-Focal 3.5X-90X Trinocular Boom-arm Soldering Microscope + 37MP Camera

BioTech 365

415,98 EURFecha de finalización: viernes sep-18-2020 23:13:16 CESTCómpralo ya por sólo: 415,98 EUR¡Cómpralo ya! | Añadir a lista de seguimiento Biotech365 : Simul-Focal 3.

article thumbnail

The New Clinical Trial Supply Chain: Resilient, Flexible, and Patient-Centric

The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.

article thumbnail

Patent delisted for Boehringer Ingelheim drug GLYXAMBI

Drug Patent Watch

Annual Drug Patent Expirations for GLYXAMBI Glyxambi is a drug marketed by Boehringer Ingelheim and is included in one NDA. It is available from two suppliers. There are eleven patents…. The post Patent delisted for Boehringer Ingelheim drug GLYXAMBI appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

CASED BRASS MICROSCOPE NICHOL PRISM POLARISATION ANALYSER + CONDENSER -NOT LEITZ

BioTech 365

32,40 EUR (0 Pujas)Fecha de finalización: sábado sep-19-2020 20:01:23 CESTPujar ahora | Añadir a lista de seguimiento Biotech365 : CASED BRASS MICROSCOPE NICHOL PRISM POLARISATION ANALYSER + CONDENSER -NOT LEITZ BioMarketplace You want to propose your products or a Biotech … Continue reading →

article thumbnail

Patent delisted for Veloxis Pharms drug ENVARSUS XR

Drug Patent Watch

Annual Drug Patent Expirations for ENVARSUS+XR Envarsus Xr is a drug marketed by Veloxis Pharms Inc and is included in one NDA. It is available from one supplier. There are…. The post Patent delisted for Veloxis Pharms drug ENVARSUS XR appeared first on DrugPatentWatch - Make Better Decisions.

Drugs 52
article thumbnail

Large Prospective Lung Cancer Study To Be Presented at ESMO Congress Shows Idyllaâ„¢ Reduces EGFR Mutation Testing Turnaround Time by More than a Week, Allowing Faster Patient Management Decisions

BioTech 365

PRESS RELEASE 14 September 2020, 07:00 CEST Large Prospective Lung Cancer Study To Be Presented at ESMO Congress Shows Idylla™ Reduces EGFR Mutation Testing Turnaround Time by More than a Week, Allowing Faster Patient Management Decisions Mechelen, Belgium, 14 September … Continue reading →

40
article thumbnail

Deliver Fast, Flexible Clinical Trial Insights with Spotfire

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.